Eric Schneider

Eric Schneider has worked in a variety of roles in the scientific field since 1999. Eric began their career as a Graduate Student at the University of Michigan, where they worked under the supervision of Dr. Michael Marletta. In 2001, they moved to UC Berkeley to continue their studies as a Graduate Student. From 2005 to 2010, Eric worked as a Post-Doctoral Scholar at the University of California, San Francisco, where they conducted research on antibody protease inhibitors in the laboratory of Dr. Charles Craik. Since 2010, Eric has been employed as a Principal Scientist II at ProLynx.

Eric Schneider earned a B.A. in Chemistry from Saint John's University in 1998. Eric then attended the University of Michigan for two years, studying Medicinal Chemistry. In 2001, Eric earned a Ph.D. in Biochemistry from the University of California, Berkeley.